Clinical implications of clotting screens

International Journal of Laboratory Hematology

Volumn 37, Issue 1, 2015, Pages 8-13

  Thorell, S E ^a   Nash, M J ^b   Thachil, J ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Coagulation; Fresh frozen plasma; Prothrombin time; Thromboplastin time

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 7; FIBRINOGEN;

ARTICLE; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 7 DEFICIENCY; HUMAN; MAJOR CLINICAL STUDY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK FACTOR; TERTIARY CARE CENTER; BLOOD; BLOOD CLOTTING TEST; BLOOD COAGULATION DISORDERS; PROCEDURES; RETROSPECTIVE STUDY;

BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; HUMANS; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; RETROSPECTIVE STUDIES; TERTIARY CARE CENTERS;

EID: 84921064497     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/ijlh.12206     Document Type: Article

References (5)

1. Desborough MJ, Keeling DM. How to interpret a prolonged prothrombin time or activated partial thromboplastin time. Br J Hosp Med (Lond) 2013;74:C10-2.
2. Segal JB, Dzik WH; Transfusion Medicine/Hemostasis Clinical Trials Network. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion 2005;45:1413-25.
3. Stanworth SJ, Brunskill SJ, Hyde CJ, McClelland DB, Murphy MF. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol 2004;126:139-52.
4. Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med 2011;365:147-56.
5. Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood 2004;104:1243-52.